zur Startseite Food Mafia. Das Buch.
zur Startseite
zur Startseite



Germany's Webzine LifeGen.de for Sale

FOOD MAFIA - Wehren Sie sich gegen die skrupellosen Methoden der Lebensmittelindustrie

RUSSLAND-INTERVIEW: Peter Scholl-Latour vermisst Europas Außenpolitik

Die Pille gegen Akne: Deutlich ansprechender

Wie die Gesundheitspolitik das Leben suizidaler Kinder gefährdet

Gastbeitrag: Wie man die Target-Schulden tilgen kann

Orgasmus pur: Der G-Punkt als weibliche Prostata

Sinn und Scherben®: Clay Sculptures and Art News

Energiewende: GeneSys erzeugt in 3 Kilometer Tiefe Wärmetauscher

Hans-Werner Sinn: Gastbeitrag zur globalen Finanzkrise

Radionuklide: Staatliche Forschung deklassiert Big Pharma

Ehec: Interview mit IVI-Direktor Christian Griot

vfa Pharmabranche im Gespräch mit LifeGen.de

Porno-Branche im Visier der Seuchenforschung

Bundesrepublik stellt sich auf massiven Anstieg der Inflation ein

Energiekrise: Wasserstoff macht Benzin und Diesel überflüssig

Klimawandel: Norddeutschland droht auf 430 Kilometern Länge in den Fluten zu versinken

Interview: Ein Quantencode bestimmt unser Leben nach dem Tod

Codierte Nano-Drähte entlarven Biowaffen

Neuromarketing nimmt Kinder ins Visier

Gefahren aus der Zwergenwelt

Auf der Suche nach dem Orgasmus-Hormon

Interview mit Prof. Rudi Balling, GBF

Die Jagd auf das 1000-Dollar Genom

Jens Reich im Gespräch mit LifeGen.de

Pflanzenviren auf dem Vormarsch

Chinas unaufhaltsamer Biotech-Aufstieg

Functional Food im Gartenbau:
Obst und Gemüse zwischen Hoffnung und Kommerz


LifeGen.de® is published by
LIFEGEN.DE LTD
London, UK

Imprint

AGB

(c) 2001-2011 für alle Beiträge bei LifeGen.de®


Dieser Artikel ist kostenlos.

weitere kostenlose Artikel

Baxter H5N1 Contamination: Causes were a unique combination of process, technical and human errors

Influenza-Virus: Credit: NIAIDSince we started our coverage of the Baxter-Contamination Story in Europe shares of the big pharmaceutical company in Deerfield, IL have lost more more than 8 percent in two days, as a look at Google Finance reveals. Baxter's Chief of Communications in the US, Christopher Bona, supported our idea for an exclusive interview, so Jutta Brenn-Vogt, Manager Communications at Baxter Deutschland GmbH explained LifeGen.de what really happened with H5N1, and how security measures - not only at Baxter - should work on a global scale.


LifeGen.de: How and when did Baxter find out about the contamination?



Brenn-Vogt: A suspicion concerning a potential contamination arose at AVIR Greenhills' contracted lab in the Czech Republic during the late afternoon of Friday, February 6. Baxter was then notified by AVIR Greenhills about this situation in three locations (Slovenia, Czech Republic, Austria) during the early evening of Friday, February 6. The last notification was on February 17 from AVIR Greenhills regarding a laboratory in Germany.

LifeGen.de: Promed mentions H5N1 and/or H3N2 as contaminants. Could you describe us what exactly happened to the charges?

Brenn-Vogt: Firstly, the material that was contaminated with H5N1 was not a vaccine, but was an experimental virus material. The impacted material was made at Baxter’s facility in Orth, Austria. It was produced exclusively for laboratory testing for AVIR Greenhills. It was not used for product production or for use in humans.

The root cause of the incident has been identified. It was due to a unique combination of process, technical and human error in a procedure used for this specific research project in our facility in Austria (Orth). The chances of such a confluence of events repeating itself are virtually impossible. Cross-contamination of commercial product, clinical material or other experimental material has been absolutely excluded. The public health authorities in Austria performed an audit at Baxter’s research facility in Austria and Baxter’s corrective and preventative actions were found appropriate by the auditors. The contamination occurred only during the process for this specific research project for AVIR Greenhills in Baxter’s facility.

The employees who may have been exposed to this material have gone through a specific examination by infectious disease specialists. These people were tested or considered by disease specialists not to be at risk. The results of all performed tests were negative.

LifeGen.de: Baxter is handling H5N1 in BSL3 labs. Where is the security lack of the system? In other words: How could the charges get in European 4 countries without intention?

Brenn-Vogt: As this material was not produced for human use, testing for potential contamination is not routinely carried out. Baxter sent this material to AVIR Greenhills in Austria, they, in turn, reported to us later that they sent it to four labs with whom they contract. As explained above, this was not the result of a lack of security but it was due to a unique combination of process, technical and human error in a procedure used for this specific research project.

LifeGen.de: Do you think smaller companies like Avir Green Hills Biotechnology should handle Baxter's charges?

Brenn-Vogt: Baxter is contracted to provide influenza virus material to AVIR Greenhills for that company's use in developing their influenza vaccine. In this case, Baxter produced one component of the influenza vaccine. The individuals working with the experimental material were operating in laboratory containment conditions specifically designed to prevent exposure. We see no need to speculate on how the size of a lab had bearing on this incident.

LifeGen.de: After the Antrhrax mailings in 2001, which is no Baxter related case, but not less risky, this is the second virological contamination starting directly from the US. How will Baxter prevent future accidents like the one in Europe for the future?

Brenn-Vogt: Exposure was highly unlikely -- the individuals working with the experimental material were operating in laboratory containment conditions specifically designed to prevent exposure. All H5N1 infections that have been reported to date have been associated with direct exposure to infected poultry/birds.

As mentioned above, this incident originated in Austria, not the US. The circumstances of the contamination were a unique combination of process, technical and human errors. Cross-contamination of commercial product, clinical material or other experimental material has been absolutely excluded. The public health authorities in Austria performed an audit at Baxter’s research facility in Austria (Feb. 16) and Baxter’s corrective and preventative actions were found appropriate by the auditors. The contamination occurred only during the process for this specific research project for AVIR Greenhills in Baxter’s facility. Further details about the process will not be discussed as it is proprietary information.

LifeGen.de: Will the contamination in Europe lead to management changes in your company?

Brenn-Vogt: No.

questions by Vlad Georgescu



About LifeGen.de:

The special interest online-magazine LifeGen.de reaches more than 90.000 unique users coming from 146 countries worldwide. The magazine is read by the scientific community, by members of political institutions and by major public media. LifeGen.de was founded in 2001 an is considered to be one of Europes most important lifescience Online-Magazines. More than 7100 articles can be found at the German Business Information (GENIOS)


(2009-03-03)

Für den Volltext-Zugang zu unseren Inhalten bitte mit Ihrem Usernamen/Passwort hier einloggen, wenn Sie bereits zahlender Abonnent von LifeGen.de sind.

Sie möchten alle unsere Inhalte lesen? Dann beziehen Sie einfach ein Abonnement. Bezahlen Sie einfach über Paypal, indem Sie den Buttom in der rechten Spalte anklicken. Die Zugangsdaten erhalten Sie dann via Email zugeschickt.

Username:

Passwort:


Passwort vergessen?
     
Bestellen Sie unseren KOSTENLOSEN Newsletter mit dem Nachrichten-Überblick

daily news for the life sciences !
anmelden abmelden


Den CETA-Hammer aufhalten

LifeGen.de abonnieren




Member of The Internet Defense League







Translated by Google

LifeGen.de in English

LifeGen.de in Russian

LifeGen.de in Japanese

LifeGen.de in Chinese

LifeGen.de in Arabic



LifeGen.de als
RSS Feed
an dieser Stelle



Unterstützen Sie die Arbeit von LifeGen.de!


Spenden Sie den Betrag Ihrer Wahl an die email-Adresse info@lifegen.de direkt von Ihrem PayPal-Konto aus.



About LifeGen.de
The special interest online-magazine LifeGen.de reaches more than 270.000 unique users every year coming from 146 countries worldwide (Data provided by Google Analytics (TM)). The magazine is read by the scientific community, by members of political institutions and by major public media. LifeGen.de was founded in 2001. More than 10.000 articles can be found at the German Business Information (GENIOS).



Unsere Suchmaschine unterscheidet zwischen Groß- und Kleinschreibung. Um die gefundenen Artikel kostenlos lesen zu können, benötigen Sie ein Abonnement . Die kostenlose Volltextsuche können Sie auch über GENIOS German Business Information starten.


Deutscher Ethikrat
Datenbank-Infosystem
(DBIS)

Universitätsklinikum
Heidelberg

Universitätsklinikum Gießen
Universitätsbibliothek Bochum
Deutsche Zentralbibliothek für Medizin (ZB MED)
Trust for America's Health
(TFAH)

Net News Global
Transparency International
Deutschland e.V.

Trasylol-Injury-Lawyers.com
Tuteur & Associates, LLC

Artikel bei
SPIEGEL ONLINE

Arzneimittel - Wenn Kinder keinen Gewinn versprechen

Kollaps des Rentensystems

PARTNER

Zugang zur
MediaClinic

Brainfood:
Sachbücher

- kein Mainstream



cover